Your browser doesn't support javascript.
loading
Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma.
Eertink, J J; Zwezerijnen, G J C; Heymans, M W; Pieplenbosch, S; Wiegers, S E; Dührsen, U; Hüttmann, A; Kurch, L; Hanoun, C; Lugtenburg, P J; Barrington, S F; Mikhaeel, N G; Ceriani, L; Zucca, E; Czibor, S; Györke, T; Chamuleau, M E D; Hoekstra, O S; de Vet, H C W; Boellaard, R; Zijlstra, J M.
Afiliação
  • Eertink JJ; Hematology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Zwezerijnen GJC; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Heymans MW; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Pieplenbosch S; Radiology and Nuclear Medicine, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Wiegers SE; Epidemiology and Data Science, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Dührsen U; Methodology, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.
  • Hüttmann A; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Kurch L; Radiology and Nuclear Medicine, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Hanoun C; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Lugtenburg PJ; Radiology and Nuclear Medicine, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Barrington SF; Department of Hematology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Mikhaeel NG; Department of Hematology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Ceriani L; Klinik und Poliklinik für Nuklearmedizin, Universitätsklinikum Leipzig, Leipzig, Germany.
  • Zucca E; Department of Hematology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Czibor S; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Györke T; King's College London and Guy's and St Thomas' PET Centre, School of Biomedical Engineering and Imaging Sciences, King's Health Partners, King's College London, London, United Kingdom.
  • Chamuleau MED; Department of Clinical Oncology, Guy's Cancer Centre and School of Cancer and Pharmaceutical Sciences, King's College London University, London, United Kingdom.
  • Hoekstra OS; Department of Nuclear Medicine and PET/CT Centre, Imaging Institute of Southern Switzerland, Università della Svizzera Italiana, Bellinzona, Switzerland.
  • de Vet HCW; SAKK Swiss Group for Clinical Cancer Research, Bern, Switzerland.
  • Boellaard R; SAKK Swiss Group for Clinical Cancer Research, Bern, Switzerland.
  • Zijlstra JM; Department of Oncology, IOSI - Oncology Institute of Southern Switzerland, Università della Svizzera Italiana, Bellinzona, Switzerland.
Blood ; 141(25): 3055-3064, 2023 06 22.
Article em En | MEDLINE | ID: mdl-37001036
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article